Document 0438 DOCN M9550438 TI Growth impairment, IGF I hyposecretion and thyroid dysfunction in children with perinatal HIV-1 infection. DT 9505 AU Matarazzo P; Palomba E; Lala R; Ciuti E; Altare F; de Sanctis L; Tovo PA; Department of Paediatric Endocrinology, Regina Margherita; Children's Hospital, Turin, Italy. SO Acta Paediatr. 1994 Oct;83(10):1029-34. Unique Identifier : AIDSLINE MED/95143841 AB We evaluated the growth pattern, bone age, insulin-like growth factor I (IGF I) secretion and thyroid function in 24 perinatally infected children: 9 asymptomatic or paucisymptomatic (group 1) and 15 with a more advanced disease state and treated with zidovudine (group 2). Statural and ponderal growth were compared with those of 37 at-risk children who seroreverted. During the two-year follow-up, 22% of children in group 1 had impaired growth, 33% bone age delay, 45% reduced IGF I levels but none had thyroid dysfunction. In group 2, 53% had growth failure, 53% bone age delay, 86% reduced IGF I levels and 40% thyroid dysfunction. Among seroreverters, none showed growth impairment; statistically significant differences were found for height, weight and height velocity between perinatally infected children and seroreverters. Since auxological and hormonal evaluations run parallel to the clinical course of infection, these indices may be useful in monitoring disease progression. DE Age Determination by Skeleton Child Child, Preschool Disease Progression Female Growth Disorders/MICROBIOLOGY/*PHYSIOPATHOLOGY Human HIV Infections/CONGENITAL/COMPLICATIONS/*PHYSIOPATHOLOGY HIV Seropositivity/PHYSIOPATHOLOGY *HIV-1/IMMUNOLOGY Infant Infant, Newborn Insulin-Like Growth Factor I/*SECRETION Male Support, Non-U.S. Gov't Thyroid Gland/*PHYSIOPATHOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).